A 55-year-old man with type 2 diabetes mellitus for 8 years attends your clinic. He has no known cardiovascular disease and no chronic kidney disease. His LDL-C is 3.2 mmol/L, HDL-C is 1.0 mmol/L, and his 10-year Framingham cardiovascular risk is 18%. According to the 2021 Canadian Cardiovascular Society dyslipidaemia guideline, what is the most appropriate lipid-lowering strategy?